Dr. Carlos A. Sobral, MD

Dr. Sobral practices at Caduceus Medical Group in Yorba Linda, California.

Dr. Sobral's NPI, 1891796603, was assigned on August 2, 2005. Dr. Sobral graduated from Universidad Autonoma de Guadalajara in 1974. Dr. Sobral holds California license A30422.

Dr. Sobral's primary practice is Caduceus Medical Group, at 18200 Yorba Linda Blvd, Yorba Linda, CA 92886. The practice phone is (949) 499-0577.

Dr. Sobral's primary practice is Caduceus Medical Group in Yorba Linda, California. Dr. Sobral is also affiliated with UCI Health - Orange. The medical group on file is Caduceus Medical Group. Dmand AI also links Dr. Sobral to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Sobral's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sobral practices, 5 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Sobral's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Sobral is licensed in California.

Dmand AI lists acid reflux, acute gastroduodenitis, acute sinusitis, acute skin infection, ADHD, adjustment disease, anxiety and asthma among the conditions Dr. Sobral treats.

CMS data shows 3,363 Medicare services from Dr. Sobral across 16 procedure codes in 2024, for 1,244 Medicare patients. Medicare paid $277,361 for them. Every service was in an office.

CMS counts 1,244 Medicare patients who saw Dr. Sobral in 2024. The largest group is 65 to 74, with 698 patients. 70% of them have high cholesterol, and 60% have high blood pressure. 20% are also on Medicaid. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sobral's median patient age at 52, with 55% women.

In 2024, Dr. Sobral wrote 4,106 Medicare Part D claims for 510 patients. 88% of them were for generic drugs. CMS names the drug for 3,404 of them, across 84 drugs with 11 or more claims each, at $317,004 in total drug cost. In 2023, CMS named 2,820 claims across 75 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Sobral for performance year 2024, reported individually. Dr. Sobral accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sobral as offering telehealth.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 75 general payments to Dr. Sobral from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Amarin Pharma Inc. paid the most, $740.

Dmand AI lists 3 awards for Dr. Sobral, most recently NCQA PCMH in 2015.

Dr. Sobral graduated from Universidad Autonoma de Guadalajara in 1974.

Dr. Sobral is in network with 13 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.